Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2021	$ 453,643	$ 5	$ 685,459	$ (231,766)	$ (55)
Beginning balance, Shares at Dec. 31, 2021		54,761
Issuance of common stock upon exercise of stock options and vesting of restricted stock units, shares		356
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	2,049	$ 1	2,048
Stock-based compensation expense	4,269		4,269
Other comprehensive loss	(1,482)				(1,482)
Net loss	(31,684)			(31,684)
Ending balance at Mar. 31, 2022	426,795	$ 6	691,776	(263,450)	(1,537)
Ending balance, Shares at Mar. 31, 2022		55,117
Beginning balance at Dec. 31, 2022	$ 441,941	$ 7	864,729	(419,631)	(3,164)
Beginning balance, Shares at Dec. 31, 2022	65,471	65,471
Issuance of common stock upon exercise of stock options and vesting of restricted stock units, shares		432
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	$ 1,666		1,666
Issuance Of Common Stock Under At Market Sales Agreement Net Of Offering Costs Shares		919
Issuance Of Common Stock Under At Market Sales Agreement Net Of Offering Costs	19,600		19,600
Stock-based compensation expense	7,910		7,910
Other comprehensive loss	1,453				1,453
Net loss	(60,177)			(60,177)
Ending balance at Mar. 31, 2023	$ 412,393	$ 7	$ 893,905	$ (479,808)	$ (1,711)
Ending balance, Shares at Mar. 31, 2023	66,822	66,822